Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,846,803
-$1,378,157 QoQ
Shares Held
11,313
-41.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,687
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TWIN CAPITAL MANAGEMENT INC holds $51,361,248 across 9 Drug Manufacturers - General names. ABBV ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,076 | $18,082,608 | |
| 2 | JNJ |
Johnson & Johnson
|
47,173 | $11,980,526 | |
| 3 | AMGN |
Amgen Inc
|
15,782 | $5,714,977 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,649 | $5,223,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
80,607 | $4,644,575 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
11,313 | $2,846,803 | |
| 7 | PFE |
Pfizer Inc
|
58,541 | $1,409,667 | |
| 8 | BIIB |
Biogen Inc.
|
4,465 | $964,707 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,846,803 | 11,313 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $4,224,960 | 19,426 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $4,336,511 | 18,979 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,411,552 | 23,372 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $7,499,976 | 40,405 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $8,180,917 | 39,046 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $7,081,700 | 39,852 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $7,235,272 | 36,638 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $6,353,100 | 37,040 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,652,295 | 36,531 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,916,909 | 38,181 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $5,480,041 | 36,764 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,464,177 | 25,712 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $3,482,871 | 21,854 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $4,173,739 | 25,826 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $3,418,194 | 25,469 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $3,904,661 | 25,494 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,116,621 | 25,394 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $3,449,179 | 25,474 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,992,745 | 27,744 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $3,654,492 | 32,444 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $3,410,553 | 31,515 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $4,108,666 | 38,345 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,486,097 | 51,217 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $5,300,541 | 53,988 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $3,241,808 | 42,549 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||